Ph.D. Paul A. Wagner - 15 Dec 2022 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
CEO, President, Secretary and Chair of the Board, Director
Signature
/s/ Paul A. Wagner, Ph.D
Issuer symbol
FBRX
Transactions as of
15 Dec 2022
Net transactions value
+$104,672
Form type
4
Filing time
19 Dec 2022, 15:21:25 UTC
Previous filing
16 May 2022
Next filing
23 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBRX Common Stock Purchase $57,672 +55,976 +4.4% $1.03 1,335,025 15 Dec 2022 Direct F1
transaction FBRX Common Stock Purchase $47,000 +44,024 +3.3% $1.07 1,379,049 16 Dec 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 55,976 shares purchased in the price range of $1.00 to $1.08 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 44,024 shares purchased in the price range of $1.03 to $1.09 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Remarks:

CEO, President, Secretary and Chair of the Board